• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用 Amplatzer 房间隔封堵器闭合继发孔型房间隔缺损:前瞻性、多中心、上市后研究。

Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study.

机构信息

From the Children's Hospital of Michigan, Detroit (D.R.T.); Wayne State University, Detroit, MI (D.R.T.); Valley Children's Hospital, Madera, CA (C.Y.O.); East Carolina University, Greenville, NC (C.J.S.); Driscoll Children's Hospital, Corpus Christi, TX (M.K.); and University of Virginia, Charlottesville (D.S.L.).

出版信息

Circ Cardiovasc Interv. 2017 Aug;10(8):e004212. doi: 10.1161/CIRCINTERVENTIONS.116.004212.

DOI:10.1161/CIRCINTERVENTIONS.116.004212
PMID:28801537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5559192/
Abstract

BACKGROUND

Prospective data on the medium-term safety and effectiveness of the AMPLATZER Septal Occluder in clinical practice are not available. The objective of this study was to prospectively evaluate the risk of hemodynamic compromise and obtain medium-term survival data on patients implanted with the AMPLATZER Septal Occluder for percutaneous closure of secundum atrial septal defects.

METHODS AND RESULTS

Subjects were enrolled prospectively at 50 US sites and followed for 2 years. Between 2008 and 2012, atrial septal defect closure with the AMPLATZER Septal Occluder was attempted in 1000 patients (aged 0.3-83.6 years, mean 21±22 years). Procedural closure occurred in 97.9%, with 1-month and 2-year closure 98.5% and 97.9%, respectively. Hemodynamic compromise occurred in 6 subjects (0.65%), because of dysrhythmia in 2, device embolization in 1, and cardiac erosion in 3. The rate of cardiac erosion was 0.3% (average 83, range 12-171 days from implant).

CONCLUSIONS

Closure of atrial septal defect with the AMPLATZER Septal Occluder is safe and effective. The rate of hemodynamic compromise and cardiac erosion is rare. The risk factors for cardiac erosion after device closure are not yet clear.

CLINICAL TRIAL REGISTRATION

URL: http://www.clinicaltrials.gov. Unique identifier: NCT00650936.

摘要

背景

目前尚无 AMPLATZER 房间隔封堵器在临床实践中的中期安全性和有效性的前瞻性数据。本研究的目的是前瞻性评估血液动力学受损的风险,并获得经皮植入 AMPLATZER 房间隔封堵器治疗继发房间隔缺损患者的中期生存数据。

方法和结果

在 50 个美国地点前瞻性招募受试者,并随访 2 年。2008 年至 2012 年,1000 例患者(年龄 0.3-83.6 岁,平均 21±22 岁)尝试采用 AMPLATZER 房间隔封堵器进行房间隔缺损封堵。97.9%的患者进行了手术封堵,1 个月和 2 年的封堵率分别为 98.5%和 97.9%。6 例(0.65%)患者发生血液动力学受损,其中 2 例发生心律失常,1 例发生器械栓塞,3 例发生心脏侵蚀。心脏侵蚀的发生率为 0.3%(平均 83 天,植入后 12-171 天)。

结论

采用 AMPLATZER 房间隔封堵器封堵房间隔缺损安全有效。血液动力学受损和心脏侵蚀的发生率较低。器械封堵后发生心脏侵蚀的危险因素尚不清楚。

临床试验注册

网址:http://www.clinicaltrials.gov。唯一标识符:NCT00650936。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6282/5559192/2f8c258f915c/hcv-10-e004212-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6282/5559192/2f8c258f915c/hcv-10-e004212-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6282/5559192/2f8c258f915c/hcv-10-e004212-g003.jpg

相似文献

1
Closure of Secundum Atrial Septal Defects With the AMPLATZER Septal Occluder: A Prospective, Multicenter, Post-Approval Study.应用 Amplatzer 房间隔封堵器闭合继发孔型房间隔缺损:前瞻性、多中心、上市后研究。
Circ Cardiovasc Interv. 2017 Aug;10(8):e004212. doi: 10.1161/CIRCINTERVENTIONS.116.004212.
2
Comparative effectiveness of devices for transcatheter closure of atrial septal defects: Systematic review and network meta-analysis.经导管封堵房间隔缺损装置的比较效果:系统评价与网状Meta分析
Arch Cardiovasc Dis. 2022 Dec;115(12):664-674. doi: 10.1016/j.acvd.2022.09.002. Epub 2022 Oct 22.
3
Safety and one-year follow-up analysis of percutaneous ASD closure at a tertiary care hospital.一家三级医疗医院经皮房间隔缺损封堵术的安全性及一年随访分析
Indian Heart J. 2025 May-Jun;77(3):199-203. doi: 10.1016/j.ihj.2025.03.011. Epub 2025 Mar 27.
4
Current Trends in Device and Size Selection for Transcatheter Atrial Septal Defect Closure in Adults - Insights From a Japanese Nationwide Registry.成人经导管房间隔缺损封堵术的器械与尺寸选择的当前趋势——来自日本全国性注册研究的见解
Circ J. 2025 Jun 25;89(7):939-945. doi: 10.1253/circj.CJ-24-0944. Epub 2025 May 10.
5
Systematic review of multiple versus single device closure of Secundum atrial septal defects in adults.成人继发房间隔缺损的多种与单一器械封堵的系统评价。
Cardiovasc Revasc Med. 2024 Jan;58:90-97. doi: 10.1016/j.carrev.2023.07.027. Epub 2023 Aug 3.
6
Short and Mid-term Outcomes of Percutaneous Perimembranous Ventricular Septal Defect Closure Using Amplatzer Duct Occluders Type II in Children and Adolescents.应用Amplatzer II型动脉导管封堵器经皮闭合儿童及青少年膜周部室间隔缺损的近期和中期疗效
Iran J Med Sci. 2025 Jun 1;50(6):393-403. doi: 10.30476/ijms.2024.102819.3595. eCollection 2025 Jun.
7
Hemodynamic Changes After Wire Frame Occluders vs. Metal Mesh Devices for Atrial Septal Defect.用于房间隔缺损的线框封堵器与金属网装置后的血流动力学变化。
Circ J. 2025 Jun 25;89(7):930-938. doi: 10.1253/circj.CJ-24-0966. Epub 2025 Mar 27.
8
Secundum atrial septal defects in adults: all you need to know with an emphasis on outcome.成人继发孔型房间隔缺损:你需要了解的一切,重点关注治疗结果
Expert Rev Cardiovasc Ther. 2025 Apr;23(4):165-178. doi: 10.1080/14779072.2025.2495235. Epub 2025 May 2.
9
Efficacy and Safety of the LifeTech™ Multifunctional Occluder (Konar-MFO) in Transcatheter Closure of Ventricular Septal Defects: A Systematic Review and Meta-Analysis.LifeTech™多功能封堵器(Konar-MFO)经导管封堵室间隔缺损的有效性和安全性:一项系统评价和荟萃分析
Catheter Cardiovasc Interv. 2025 Apr 24. doi: 10.1002/ccd.31560.
10
Ceraflex versus Amplatzer occluder for secundum atrial septal defect closure. Multicenter clinical experience.Ceraflex封堵器与Amplatzer封堵器用于继发孔型房间隔缺损封堵的多中心临床经验
Herz. 2015 Apr;40 Suppl 2:146-50. doi: 10.1007/s00059-014-4192-0. Epub 2015 Feb 8.

引用本文的文献

1
Biodegradable polymeric occluder with controllable locking structure for closure of atrial septal defect via interventional treatment.具有可控锁定结构的可生物降解聚合物封堵器,用于通过介入治疗闭合房间隔缺损。
Regen Biomater. 2025 Mar 20;12:rbaf016. doi: 10.1093/rb/rbaf016. eCollection 2025.
2
Percutaneous atrial septal defect closure in limited-resource setting: a decade-long experience from Ethiopia.资源有限地区的经皮房间隔缺损封堵术:埃塞俄比亚长达十年的经验
Front Cardiovasc Med. 2025 Feb 18;12:1550693. doi: 10.3389/fcvm.2025.1550693. eCollection 2025.
3
Interventions for adult congenital heart disease.

本文引用的文献

1
The influence of deficient retro-aortic rim on technical success and early adverse events following device closure of secundum atrial septal defects: An Analysis of the IMPACT Registry.主动脉后缘缺损对继发孔型房间隔缺损封堵术后技术成功率和早期不良事件的影响:IMPACT注册研究分析
Catheter Cardiovasc Interv. 2017 Jan;89(1):102-111. doi: 10.1002/ccd.26585. Epub 2016 May 18.
2
Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case-Control Study.经导管封堵房间隔缺损后心脏侵蚀的相关危险因素:一项病例对照研究。
Circulation. 2016 May 3;133(18):1738-46. doi: 10.1161/CIRCULATIONAHA.115.019987. Epub 2016 Mar 21.
3
成人先天性心脏病的干预措施。
Nat Rev Cardiol. 2025 Jan 20. doi: 10.1038/s41569-025-01118-1.
4
Transcatheter Interventions in Patients With Adult Congenital Heart Disease.成人先天性心脏病患者的经导管介入治疗
J Soc Cardiovasc Angiogr Interv. 2022 Aug 24;1(6):100438. doi: 10.1016/j.jscai.2022.100438. eCollection 2022 Nov-Dec.
5
Recent Development of Biodegradable Occlusion Devices for Intra-Atrial Shunts.用于心房分流的可生物降解封堵装置的最新进展
Rev Cardiovasc Med. 2024 May 8;25(5):159. doi: 10.31083/j.rcm2505159. eCollection 2024 May.
6
Do we need another device for catheter interventional closure of septum secundum atrial septal defects?我们是否需要另一种用于经导管介入封堵继发孔型房间隔缺损的装置?
EuroIntervention. 2023 Nov 17;19(9):710-711. doi: 10.4244/EIJ-E-23-00042.
7
Transcatheter Closure of Atrial Septal Defect: A Review of Currently Used Devices.经导管封堵房间隔缺损:当前使用装置的综述
Cureus. 2023 Jun 8;15(6):e40132. doi: 10.7759/cureus.40132. eCollection 2023 Jun.
8
Minimal-Access Atrial Septal Defect (ASD) Closure.微创房间隔缺损封堵术
J Cardiovasc Dev Dis. 2023 May 10;10(5):206. doi: 10.3390/jcdd10050206.
9
Mitral Valve Surgery in Patients With an Implanted Amplatzer Septal Occluder: A Review of 2 Cases.经植入 Amplatzer 房间隔封堵器患者的二尖瓣手术:2 例报告
Tex Heart Inst J. 2023 Jan 1;50(1). doi: 10.14503/THIJ-21-7563.
10
A Novel Puncturable Atrial Septal Defect Occluder: The Results of Preclinical Experiment and First-in-Human Study.一种新型可穿刺房间隔缺损封堵器:临床前实验及首次人体研究结果
JACC Basic Transl Sci. 2022 Oct 26;7(12):1200-1210. doi: 10.1016/j.jacbts.2022.06.010. eCollection 2022 Dec.
Transcatheter Versus Surgical Closure of Atrial Septal Defects in Children: A Value Comparison.
经导管与手术关闭儿童房间隔缺损:价值比较。
JACC Cardiovasc Interv. 2016 Jan 11;9(1):79-86. doi: 10.1016/j.jcin.2015.09.028.
4
Prevalence of deficient retro-aortic rim and its effects on outcomes in device closure of atrial septal defects.主动脉后间隙不足的患病率及其对房间隔缺损封堵术结局的影响。
Pediatr Cardiol. 2014 Oct;35(7):1181-90. doi: 10.1007/s00246-014-0914-6. Epub 2014 May 14.
5
Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement.经胸超声心动图预测 Amplatzer 房间隔封堵器放置后心脏侵蚀。
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):84-92. doi: 10.1002/ccd.25175. Epub 2013 Sep 30.
6
Very late erosion of Amplatzer septal occluder device presenting as pericardial pain and effusion 8 years after placement.Amplatzer 房间隔封堵器 8 年后迟发穿孔致心包疼痛和积液。
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E592-4. doi: 10.1002/ccd.24755. Epub 2013 Mar 18.
7
Erosions, erosions, and erosions! Device closure of atrial septal defects: how safe is safe?侵蚀,侵蚀,还是侵蚀!房间隔缺损的器械封堵术:多安全才算安全?
Catheter Cardiovasc Interv. 2012 Aug 1;80(2):168-74. doi: 10.1002/ccd.24517.
8
Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature.经皮房间隔封堵器装置与心脏侵蚀:文献复习。
Catheter Cardiovasc Interv. 2012 Aug 1;80(2):157-67. doi: 10.1002/ccd.24347. Epub 2012 May 2.
9
Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect.经导管或手术治疗血流动力学显著的单纯继发孔房间隔缺损的 5 年至 20 年的长期结果。
Am J Cardiol. 2012 May 1;109(9):1348-52. doi: 10.1016/j.amjcard.2011.12.031. Epub 2012 Feb 13.
10
Percutaneous versus surgical closure of secundum atrial septal defects: a systematic review and meta-analysis of currently available clinical evidence.经皮与手术闭合继发房间隔缺损的比较:现有临床证据的系统评价和荟萃分析。
EuroIntervention. 2011 Jul;7(3):377-85. doi: 10.4244/EIJV7I3A63.